Dashboard
Manage Tickers

RMDRESMED INC

NYSE resmed.com


$ 218.05 $ 34.64 (18.89 %)    

Friday, 26-Apr-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 218.06
$ 203.46
$ 0.00 x 0
$ 0.00 x 0
$ 201.86 - $ 218.36
$ 131.49 - $ 241.04
4,330,840
na
32.15B
$ 0.99
$ 33.55
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 01-25-2024 12-31-2023 10-Q
3 10-26-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-K
5 04-28-2023 03-31-2023 10-Q
6 01-27-2023 12-31-2022 10-Q
7 10-28-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-K
9 04-28-2022 03-31-2022 10-Q
10 01-27-2022 12-31-2021 10-Q
11 10-28-2021 09-30-2021 10-Q
12 08-17-2021 06-30-2021 10-K
13 04-30-2021 03-31-2021 10-Q
14 01-29-2021 12-31-2020 10-Q
15 10-30-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-K
17 05-01-2020 03-31-2020 10-Q
18 01-31-2020 12-31-2019 10-Q
19 10-25-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-K
21 05-03-2019 03-31-2019 10-Q
22 02-01-2019 12-31-2018 10-Q
23 10-26-2018 09-30-2018 10-Q
24 08-17-2018 06-30-2018 10-K
25 04-27-2018 03-31-2018 10-Q
26 01-24-2018 12-31-2017 10-Q
27 10-27-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-K
29 04-28-2017 03-31-2017 10-Q
30 01-25-2017 12-31-2016 10-Q
31 10-28-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-K
33 04-29-2016 03-31-2016 10-Q
34 01-28-2016 12-31-2015 10-Q
35 10-27-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-K
37 04-29-2015 03-31-2015 10-Q
38 01-30-2015 12-31-2014 10-Q
39 10-31-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-aon-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Aon Shares Are Trading Lower By Around...
04/26/2024 17:56:57

oppenheimer-maintains-outperform-on-resmed-lowers-price-target-to-200
Oppenheimer Maintains Outperform on ResMed...
04/26/2024 17:55:07

Oppenheimer analyst Suraj Kalia maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $205 to $200.

rbc-capital-maintains-sector-perform-on-resmed-raises-price-target-to-200
RBC Capital Maintains Sector Perform on Re...
04/26/2024 15:54:44

RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Sector Perform and raises the price target from $187 t...

skechers-reports-upbeat-earnings-joins-tutor-perini-appfolio-newell-brands-and-other-big-stocks-moving-higher-on-friday
Skechers Reports Upbeat Earnings, Joins Tu...
04/26/2024 14:45:17

resmed-analysts-boost-their-forecasts-after-better-than-expected-earnings
ResMed Analysts Boost Their Forecasts Afte...
04/26/2024 12:47:41

keybanc-maintains-overweight-on-resmed-raises-price-target-to-238
Keybanc Maintains Overweight on ResMed, Ra...
04/26/2024 12:40:03

Keybanc analyst Brett Fishbin maintains ResMed (NYSE:RMD) with a Overweight and raises the price target from $227 to $238.

why-alphabet-shares-are-trading-higher-by-12-here-are-20-stocks-moving-premarket
Why Alphabet Shares Are Trading Higher By ...
04/26/2024 12:18:32

wall-street-futures-ride-high-on-microsoft-alphabet-cheer-but-will-inflation-data-burst-the-bubble-why-this-analyst-thinks-bull-run-isnt-over-yet
Wall Street Futures Ride High On Microsoft...
04/26/2024 10:48:12

Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday.

needham-maintains-buy-on-resmed-raises-price-target-to-236
Needham Maintains Buy on ResMed, Raises Pr...
04/26/2024 10:24:42

Needham analyst Mike Matson maintains ResMed (NYSE:RMD) with a Buy and raises the price target from $224 to $236.

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/25/2024 20:32:50

resmed-q3-2024-adj-eps-213-beats-191-estimate-sales-1200b-beat-1167b-estimate
ResMed Q3 2024 Adj EPS $2.13 Beats $1.91 E...
04/25/2024 20:06:35

ResMed (NYSE:RMD) reported quarterly earnings of $2.13 per share which beat the analyst consensus estimate of $1.91 by 11.52 pe...

heres-how-much-you-would-have-made-owning-resmed-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
04/15/2024 16:00:26

jim-cramer-isnt-going-with-this-tech-company-its-complicated-im-a-nvidia-guy
Jim Cramer Isn't Going With This Tech Comp...
04/08/2024 12:26:10

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).

needham-maintains-buy-on-resmed-raises-price-target-to-224
Needham Maintains Buy on ResMed, Raises Pr...
04/01/2024 09:22:24

Needham analyst Mike Matson maintains ResMed (NYSE:RMD) with a Buy and raises the price target from $215 to $224.

1000-invested-in-resmed-10-years-ago-would-be-worth-this-much-today
$1000 Invested In ResMed 10 Years Ago Woul...
03/28/2024 20:30:26

expert-outlook-resmed-through-the-eyes-of-9-analysts
Expert Outlook: ResMed Through The Eyes Of...
03/27/2024 18:00:37

mizuho-maintains-buy-on-resmed-maintains-215-price-target
Mizuho Maintains Buy on ResMed, Maintains ...
03/27/2024 17:15:28

Mizuho analyst Anthony Petrone maintains ResMed (NYSE:RMD) with a Buy and maintains $215 price target.

peering-into-resmeds-recent-short-interest
Peering Into ResMed's Recent Short Interest
03/26/2024 17:00:18

keybanc-initiates-coverage-on-resmed-with-overweight-rating-announces-price-target-of-227
Keybanc Initiates Coverage On ResMed with ...
02/06/2024 12:10:47

Keybanc analyst Brett Fishbin initiates coverage on ResMed (NYSE:RMD) with a Overweight rating and announces Price Target of...

heres-how-much-you-would-have-made-owning-resmed-stock-in-the-last-15-years
Here's How Much You Would Have Made Owning...
02/01/2024 20:00:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION